SC

Stempoint Capital Portfolio holdings

AUM $583M
1-Year Est. Return 185.08%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+185.08%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$583M
AUM Growth
+$86.8M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
112
New
Increased
Reduced
Closed

Top Buys

1
+$25.6M
2
+$24.6M
3
+$16.2M
4
CNTA
Centessa Pharmaceuticals
CNTA
+$12.6M
5
ADPT icon
Adaptive Biotechnologies
ADPT
+$9.9M

Top Sells

1
+$63.7M
2
+$22.2M
3
+$21.1M
4
QURE icon
uniQure
QURE
+$18.5M
5
WVE icon
Wave Life Sciences
WVE
+$15.4M

Sector Composition

1 Healthcare 100%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZBIO
76
Zenas BioPharma
ZBIO
$1.4B
– –
-38,742
BBIO icon
77
BridgeBio Pharma
BBIO
$12.7B
– –
-127,435
BHVN icon
78
Biohaven
BHVN
$1.41B
– –
-1,017,311
CDTX
79
DELISTED
Cidara Therapeutics
CDTX
– –
-152,325
AKRO
80
DELISTED
Akero Therapeutics
AKRO
– –
-121,410
ALKS icon
81
Alkermes
ALKS
$4.81B
– –
-241,637
ARCT icon
82
Arcturus Therapeutics
ARCT
$219M
– –
-35,606
ARGX icon
83
argenx
ARGX
$46.3B
– –
-12,465
ARKG icon
84
ARK Genomic Revolution ETF
ARKG
$1.23B
– –
0
ATAI icon
85
AtaiBeckley Inc
ATAI
$1.33B
– –
-76,032
CGON icon
86
CG Oncology
CGON
$5.07B
– –
-63,019
CMPS
87
Compass Pathways
CMPS
$795M
– –
-275,620
CRSP icon
88
CRISPR Therapeutics
CRSP
$5.76B
– –
0
CRVS icon
89
Corvus Pharmaceuticals
CRVS
$1.49B
– –
-96,439
ENTA icon
90
Enanta Pharmaceuticals
ENTA
$449M
– –
-75,194
EQ icon
91
Equillium
EQ
$107M
– –
-1,908,935
GHRS icon
92
GH Research
GHRS
$966M
– –
-545,275
HROW icon
93
Harrow
HROW
$1.47B
– –
-57,619
INSM icon
94
Insmed
INSM
$32B
– –
-43,419
IONS icon
95
Ionis Pharmaceuticals
IONS
$12.7B
– –
0
JAZZ icon
96
Jazz Pharmaceuticals
JAZZ
$11.5B
– –
-39,072
KALV icon
97
KalVista Pharmaceuticals
KALV
$811M
– –
-56,770
DFTX
98
Definium Therapeutics
DFTX
$1.82B
– –
-76,875
ORIC icon
99
Oric Pharmaceuticals
ORIC
$1.55B
– –
-166,461
PEPG icon
100
PepGen
PEPG
$459M
– –
-389,189
1 2 3
4
5